Osaic Holdings
INZY

Osaic Holdings’s Inozyme Pharma INZY Stock Holding History

Osaic Holdings’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,217
Closed -$2.02K – 7810
2025
Q1 		$2.02K Buy
+2,217
New +$3.07K ﹤0.01% 6592
2024
Q4 		– Sell
-50
Closed -$262 – 7530
2024
Q3 		$262 Sell
50
-136
-73% -$706 ﹤0.01% 7133
2024
Q2 		$830 Buy
186
+136
+272% +$659 ﹤0.01% 6865
2024
Q1 		$383 Hold
50
– – ﹤0.01% 6873
2023
Q4 		$213 Hold
50
– – ﹤0.01% 7035
2023
Q3 		$210 Buy
+50
New +$254 ﹤0.01% 7144

Other funds holding INZY

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Osaic Holdings's INZY Position: Q2 2025 in Review

Osaic Holdings sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 2,217 shares — an estimated $2.02K sold.

Osaic Holdings first reported a position in INZY in Q3 2023 and held it in 6 quarters. The position peaked at $2.02K in Q1 2025. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

  • Osaic Holdings reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 2,217 Inozyme Pharma shares in Q2 2025, an estimated $2.02K.
  • Osaic Holdings first reported a position in Inozyme Pharma in Q3 2023 and held it in 6 quarters.
  • Osaic Holdings's Inozyme Pharma position peaked at $2.02K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.